In this post, we hear from Jessica to find out more about the MRC Regulatory Support Centre’s recent Human Tissue Forum meeting.
In this post we hear from Martin Farley, Sustainable Laboratory Advisor at UCL to find out more about environmental sustainability in the lab.
Biobank support and resources for those working with human tissue Biobanking and research involving human tissue and data are governed by specific regulations and are guided by existing best practice. We’ve made a list of key organisations that provide biobank support and resources for research involving human data and tissue. MRC Regulatory Support Centre The[…]
In this blog post we find out more about BBMRI-ERIC’s work on quality management service and how you can get involved.
ISO Biobank Standards Assuring researchers as to the quality or standard of a Biobank is an important issue. We are here to keep you abreast of all the latest developments in the field. You may have heard that new ISO Biobank standards are coming soon, but who is writing them and how can you get[…]
Services available for new BBMRI.uk network The UKCRC TDCC is the UK’s node within BBRMI-ERIC; we can also, therefore, be referred to as BBMRI.uk. This membership means we are part of a much larger European effort and as a result the services BBMRI develop are available to UK Biobanks. We are initiating our own BBMRI.uk[…]
New HTA codes of practice In April the Human Tissue Authority (HTA) published updated Codes of practice. This guest blog by Regulation Manager, Fiona Maleady-Crowe explains what this means for Biobanks. What are the Codes of Practice? The HTA’s Codes of Practice provide practical guidance on the human tissue legislation and set out the HTA’s[…]
Many Biobanks are under pressure to adopt more sustainable, business-like mentalities in the future. The results of a ISBER survey on business planning in the Biobanking community is outlined in this post.
The Health Research Authority (HRA) have published new guidance on taking a proportionate approach to consent, particularly in reference to clinical trials.
Accreditation Review of the CCB’s pilot audit scheme Background Biobanking is recognised as a critical area requiring development if progress is to be made in identifying clinically useful markers of disease and disease progression, discovering new drug targets and understanding the mechanisms of disease in cancer. Researchers continue to report that they are unable to[…]